You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
朗生医药(00503.HK)料中期净利较同期显著下降
格隆汇 07-25 18:28

格隆汇7月25日丨朗生医药(00503.HK)公布,集团预期截至2019年6月30日止六个月录得的净利润较截至2018年同期净利润有显著下降。

该业绩主要受以下因素影响:因受中国医药经营政策变化和集团经营策略调整,集团减少代理产品,其中玉泽的代理已经终止,而该代理产品在去年上半年仍然为集团贡献一定的销售收入;期内有若干存货进行拨备及撇账;及集团于2019年6月21日就不行使认沽萃健期权发出公告。因此,集团因认沽萃健期权撇销而录得若干损失。

公司的管理层认为经营策略改变渐见成效,预期医药分部溢利较去年同期有所上升。在集团经营层面方面,尽管今年上半年之业绩较去年同期下跌,但相比2018年12月31日止年度经营业绩,集团成功扭转经营亏损,预期截至2019年6月30日止六个月会录得经营溢利。

集团会继续以现金流及利润优先的策略,集中发展及加速研发自有产品,同时亦扩大两个覆盖,医院的覆盖及自营产品覆盖面,进一步提升集团医药业务的销售规模与盈利能力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account